CENTER ID: | GilaA.01141.a |
ORGANISM: | Giardia lamblia ATCC 50803 |
ASSOCIATED DISEASE: | Giardiasis |
CURRENT STATUS: | in PDB |
COMMUNITY REQUEST: | False |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
IIIB |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
GilaA.01141.a.A1.GE25724 | Full length( GilaA.01141.a ) | 1 | 344 | ||
GilaA.01141.a.AE1.GE43227 | Full length( GilaA.01141.a ) | 1 | 344 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
GilaA.01141.a.A1.PS00294 | Full length( GilaA.01141.a ) | 1 | 344 | ||
GilaA.01141.a.AE1.PS38632 | Full length( GilaA.01141.a ) | 1 | 344 | ||
GilaA.01141.a.A1.PW25772 | Full length( GilaA.01141.a ) | 1 | 344 |
RESOURCE | REFERENCE ID |
---|---|
EuPathDB: | GiardiaDB:GL50803_15297 |
RefSeq: | XP_001709091.1 |
UniProt: | A8B6Y7 |
HARVESTED ON: | 10/31/2008 |
SEQUENCED ON: | 7/20/2010 |
EXPECTED MW: | 38kDa |
OBSERVED MW: | 39kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | High Expression |
SOLUBLE EXPRESSION LEVEL | High Expression |
EXPRESSION HOST: | data unavailable |
SEQUENCING RESULT: | pass with incomplete coverage |
PERCENT IDENTITY: | 97 |
PERCENT COVERAGE: | 50 |
HARVESTED ON: | 6/12/2019 |
SEQUENCED ON: | 6/18/2019 |
EXPECTED MW: | 37kDa |
OBSERVED MW: | 37kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Low Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 96 |
PERCENT COVERAGE: | 100 |
PURIFICATION DATe: | 7/2/2009 |
CONCENTRATION: | 7.78mg/ml |
OBSERVED MW: | data unavailable |
EXPRESSION LEVEL: | Low Expression |
PROTEIN PURIFICATION BUFFER: | 20 mM HEPES, pH 7.0, 300 mM NaCl, 5% glycerol and 1 mM TCEP |
EXPRESSION HOST: | data unavailable |
VIAL COUNT (approx.): | 8 |
VIAL VOLUME: | 100µl |
PERCENT IDENTITY: | 97 |
PERCENT COVERAGE: | 50 |
PURIFICATION DATe: | 1/14/2020 |
CONCENTRATION: | 34.66mg/ml |
OBSERVED MW: | 37kDa |
EXPRESSION LEVEL: | Moderate Expression |
PROTEIN PURIFICATION BUFFER: | SEC: 20 mM HEPES pH 7.0, 300 mM NaCl, 5% glycerol, 1 mM TCEP |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 10 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | 96 |
PERCENT COVERAGE: | 100 |
PURIFICATION DATe: | 1/28/2009 |
CONCENTRATION: | 33.61mg/ml |
OBSERVED MW: | data unavailable |
EXPRESSION LEVEL: | High Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol , 2 mM DTT, and 0.025% Azide |
EXPRESSION HOST: | data unavailable |
VIAL COUNT (approx.): | 29 |
VIAL VOLUME: | 100µl |
PERCENT IDENTITY: | 97 |
PERCENT COVERAGE: | 50 |